Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updates the site’s displayed revision/version identifier from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:16.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2 from v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:24:03.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. No changes to study content or eligibility criteria were made.
    Difference
    0.1%
    Check dated 2026-03-18T21:58:25.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now includes a new revision note: v3.4.3. The previous revision note v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:45:34.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. Notices about government funding and the prior Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T09:27:01.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operations status has been added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:46:37.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.